Skip to content
Screener

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.53-47.5%
DexCom logo
DexComDXCM
$0.64+42.2%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$0.31+60.3%
Embecta Corp. logo
Embecta Corp.EMBC
$0.36-53.8%
Owlet logo
OwletOWLT
-$0.05+97.9%

Other financials

Income statement

See full
Revenue$14.5M+118%
Gross profit$8.6M+174%
Operating income-$36.0M-151%
Net income-$36.7M-153%

Balance sheet

See full
Cash & equivalents$44.8M+42.0%
Total debt$62.8M+52.3%
Total equity$90.3M-4.7%
Total assets$176.8M+17.7%

Cash flow

See full
Operating cash flow-$30.1M-225%
CapEx$217.0K+75.0%
Free cash flow-$30.4M-223%

Valuation

See full
Market cap$493.84M+30.3%
Enterprise value$511.91M+31.7%
P/S10.2×-4.7×

Profitability

See full
Gross margin54.9%+37.1pp
Operating margin-223.2%-24.7pp
Net margin-225.3%-30.8pp
FCF margin-199.5%-13.6pp

Returns & leverage

See full
Return on equity-118.2%-17.5pp
Debt / equity0.7×+0.3×
Current ratio6.7×-2.8×

Where this comes from

Reported directly by Senseonics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Senseonics Holdings, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:29 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-092056
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Other comprehensive loss
Unrealized (loss) gain on marketable securities(62)26(123)23
Other comprehensive (loss) gain(62)26(123)23
Total comprehensive loss$(36,767)$(14,475)$(69,161)$(28,737)
Basic net loss per common share$(0.63)$(0.36)$(1.33)$(0.75)
Basic weighted-average shares outstanding57,842,71340,668,24551,910,00638,319,113
Diluted net loss per common share$(0.63)$(0.36)$(1.33)$(0.75)
Diluted weighted-average shares outstanding57,842,71340,668,24551,910,00638,319,113

Cover / Front Matter

FAQ

What is Senseonics Holdings, Inc.'s EPS (diluted)?
Senseonics Holdings, Inc. (SENS) reported EPS (diluted) of -$0.63 in Q2 2026.
How has Senseonics Holdings, Inc.'s EPS (diluted) changed year-over-year?
Senseonics Holdings, Inc.'s EPS (diluted) decreased by 75.0% year-over-year, from -$0.36 to -$0.63.
What is the long-term trend for Senseonics Holdings, Inc.'s EPS (diluted)?
Over 3 years (2022 to 2025), Senseonics Holdings, Inc.'s EPS (diluted) has grown at a 102.5% compound annual growth rate (CAGR), from -$0.20 to -$1.66.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Senseonics Holdings, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude